Sarah Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sarah Kim has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Jong Soo Han
Department of Family Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
4 shared publications - Se Young Jung
Department of Family Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea
4 shared publications - Woo Kyung Bae
Department of Family Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
4 shared publications - Hye Yeon Koo
Department of Family Medicine, Seoul National University Bundang Hospital, Seongnam 13620, Republic of Korea
3 shared publications - In Young Cho
Samsung Medical Center, Seoul, Korea
3 shared publications - Ju Young Kim
Department of Family Medicine, Seoul National University Bundang Hospital, Seongnam-si, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 20 July 2020
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Medicine
- Vol. 41 (4) , 222-228
Risk Factors of Cardiovascular Disease according to Alcohol Behavioral Change after Cancer Diagnosis
Problem drinking increases the incidence of all-cause mortality and specific cancers, and persistent drinking is associated with cardiovascular disease in certain cancer survivors. This study analyzed the cardiovascular risk factors before and after diagnosis in Korean cancer survivors. Data for the period between 2002 and 2013 were collected from the National Health Insurance Service Health-Examinee Cohort Database. Among the 27,835 patients included, those with moderate alcohol consumption before and after cancer diagnosis were excluded. Problem drinking was defined as males under 65 years consuming over 14 glasses a week, and males over 65 years or females consuming over seven glasses a week. A t-test, chi-square test, and linear regression analysis were performed for differences in cardiovascular risk factors and differences according to cancer types. There was a difference in the body mass index, systolic and diastolic blood pressure, and total cholesterol among patients who became moderate drinkers after diagnosis, but fasting blood glucose did not show any significant changes. Risk factors for cardiovascular disease were analyzed in patients with liver, stomach, rectal, and breast cancer with improved drinking behavior, and there were significant differences in body mass index, systolic and diastolic blood pressure, fasting blood glucose, and total cholesterol in stomach cancer patients. Moderate drinking can lower cardiovascular risk in cancer survivors, and among the many drinking-related cancers, stomach cancer patients demonstrated significantly reduced cardiovascular risk factors.
- 20 July 2020
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Medicine
- Vol. 41 (4) , 222-228
Open AccessRisk Factors of Cardiovascular Disease according to Alcohol Behavioral Change after Cancer Diagnosis
Problem drinking increases the incidence of all-cause mortality and specific cancers, and persistent drinking is associated with cardiovascular disease in certain cancer survivors. This study analyzed the cardiovascular risk factors before and after diagnosis in Korean cancer survivors. Data for the period between 2002 and 2013 were collected from the National Health Insurance Service Health-Examinee Cohort Database. Among the 27,835 patients included, those with moderate alcohol consumption before and after cancer diagnosis were excluded. Problem drinking was defined as males under 65 years consuming over 14 glasses a week, and males over 65 years or females consuming over seven glasses a week. A t-test, chi-square test, and linear regression analysis were performed for differences in cardiovascular risk factors and differences according to cancer types. There was a difference in the body mass index, systolic and diastolic blood pressure, and total cholesterol among patients who became moderate drinkers after diagnosis, but fasting blood glucose did not show any significant changes. Risk factors for cardiovascular disease were analyzed in patients with liver, stomach, rectal, and breast cancer with improved drinking behavior, and there were significant differences in body mass index, systolic and diastolic blood pressure, fasting blood glucose, and total cholesterol in stomach cancer patients. Moderate drinking can lower cardiovascular risk in cancer survivors, and among the many drinking-related cancers, stomach cancer patients demonstrated significantly reduced cardiovascular risk factors.
- 20 August 2019
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Practice
- Vol. 9 (4) , 336-340
Usefulness of the Patient Health Questionnaire-2 in Screening for Depression
- 20 August 2019
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Practice
- Vol. 9 (4) , 336-340
Usefulness of the Patient Health Questionnaire-2 in Screening for Depression
- 20 April 2019
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Practice
- Vol. 9 (2) , 204-211
Dietary Patterns Assessed by the Diet Quality Index-International Among Cancer Survivors Compared with Healthy Control Subjects: Using the Korea National Health and Nutrition Examination Surveys 2013-2015
- 20 April 2019
- Published by The Korean Academy of Family Medicine - M2PI in Korean Journal of Family Practice
- Vol. 9 (2) , 204-211
Dietary Patterns Assessed by the Diet Quality Index-International Among Cancer Survivors Compared with Healthy Control Subjects: Using the Korea National Health and Nutrition Examination Surveys 2013-2015
- Open Access
- 31 March 2016
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 4 (1) , e24
Development of a Weight Loss Mobile App Linked With an Accelerometer for Use in the Clinic: Usability, Acceptability, and Early Testing of its Impact on the Patient-Doctor Relationship
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.
- 31 March 2016
- Published by JMIR Publications Inc. in JMIR mHealth and uHealth
- Vol. 4 (1) , e24
Open AccessDevelopment of a Weight Loss Mobile App Linked With an Accelerometer for Use in the Clinic: Usability, Acceptability, and Early Testing of its Impact on the Patient-Doctor Relationship
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.
- Open Access
- 1 January 2016
- Published by XMLink in Journal of Korean Medical Science
- Vol. 31 (2) , 159-163
Validation of the Korean Version of Schedule of Fatigue and Anergia: General Physician Questionnaire
Kim S, et al. J Korean Med Sci. 2016 Feb;31(2):159-163. https://doi.org/10.3346/jkms.2016.31.2.159
- 1 January 2016
- Published by XMLink in Journal of Korean Medical Science
- Vol. 31 (2) , 159-163
Open AccessValidation of the Korean Version of Schedule of Fatigue and Anergia: General Physician Questionnaire
Kim S, et al. J Korean Med Sci. 2016 Feb;31(2):159-163. https://doi.org/10.3346/jkms.2016.31.2.159
- 1 October 2012
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 24 (10) , 1153-1157
Meta-analysis
To perform meta-analyses using observational studies to assess the association between the use of selective serotonin reuptake inhibitors (SSRIs) and the risk of colorectal cancer. A systematic search of relevant studies published through February 2012 was carried out using the Medline (PubMed), Embase, and Cochrane Library databases. We reviewed the observational studies that were associated with our subject and carried out a meta-analysis. Out of 324 screened articles, six observational studies were included in the final analyses. According to this meta-analysis, the use of SSRIs was not associated with an increased risk of colorectal cancer in pooled analyses (adjusted odds ratio 0.89, 95% confidence interval 0.79–1.01). This finding was consistently observed in subgroup analyses of study area, location of colorectal cancer, duration of SSRI use, study quality, adjustment for NSAID use, and the prevalence of overweight. Our research shows that the use of SSRIs does not increase the risk of colorectal cancer. Further studies are needed to confirm the association between SSRIs and colorectal cancer.
- 1 October 2012
- Published by Wolters Kluwer Health in European Journal of Gastroenterology & Hepatology
- Vol. 24 (10) , 1153-1157
Meta-analysis
To perform meta-analyses using observational studies to assess the association between the use of selective serotonin reuptake inhibitors (SSRIs) and the risk of colorectal cancer. A systematic search of relevant studies published through February 2012 was carried out using the Medline (PubMed), Embase, and Cochrane Library databases. We reviewed the observational studies that were associated with our subject and carried out a meta-analysis. Out of 324 screened articles, six observational studies were included in the final analyses. According to this meta-analysis, the use of SSRIs was not associated with an increased risk of colorectal cancer in pooled analyses (adjusted odds ratio 0.89, 95% confidence interval 0.79–1.01). This finding was consistently observed in subgroup analyses of study area, location of colorectal cancer, duration of SSRI use, study quality, adjustment for NSAID use, and the prevalence of overweight. Our research shows that the use of SSRIs does not increase the risk of colorectal cancer. Further studies are needed to confirm the association between SSRIs and colorectal cancer.